Furthermore, an IDH1 mutation was detected in 17 samples of which two were classified as high-risk as compared to 15 that belonged to the low-risk group, suggesting that the signature selects for a GBM subtype with known differences in survival. Here, IDH1 is linked to glioblastoma.